alphaB-crystallin | ||||
---|---|---|---|---|
N (%) | N (%) | N (%) | ||
Negative | Weakly positive | Strongly positive | p-value (Pearson chi-square) | |
ER (n = 938) | <0.001 | |||
Negative | 176 (71.8) | 38 (15.5) | 31 (12.7) | |
Positive | 592 (85.4) | 61 (8.8) | 40 (5.8) | |
PgR (n = 940) | <0.001 | |||
Negative | 227 (75.4) | 38 (12.6) | 36 (12.0) | |
Positive | 543 (85.0) | 61 (9.5) | 35 (5.5) | |
Ki67 (n = 934) | <0.001 | |||
Low | 267 (89.3) | 17 (5.7) | 15 (5.0) | |
High | 499 (78.6) | 81 (12.8) | 55 (8.6) | |
BRCA1 (n = 928) | 0.676 | |||
Negative | 707 (81.9) | 91 (10.6) | 65 (7.5) | |
Positive | 52 (80.0) | 7 (10.8) | 6 (9.2) | |
BRCA1 (n = 86) | 0.045 | |||
WT | 61 (78.2) | 11 (14.1) | 6 (7.7) | |
Mutated | 4 (50.0) | 1 (12.5) | 3 (37.5) | |
p53 (n = 918) | 0.002 | |||
Negative | 384 (86.3) | 32 (7.2) | 29 (6.5) | |
Positive | 370 (78.2) | 66 (14.0) | 37 (7.8) | |
EGFR (n = 928) | <0.001 | |||
Negative | 671 (86.3) | 65 (8.4) | 41 (5.3) | |
Positive | 91 (60.3) | 32 (21.2) | 28 (18.5) | |
CK5 (n = 923) | <0.001 | |||
Negative | 694 (86.5) | 67 (8.4) | 41 (5.1) | |
Positive | 63 (52.1) | 31 (25.6) | 27 (22.3) | |
CK14 (n = 925) | <0.001 | |||
Negative | 750 (83.9) | 88 (9.8) | 56 (6.3) | |
Positive | 9 (29.0) | 10 (32.3) | 12 (38.7) | |
CK17 (n = 909) | <0.001 | |||
Negative | 742 (83.9) | 87 (9.9) | 55 (6.2) | |
Positive | 5 (20.0) | 9 (36.0) | 11 (44) |